[Use of amino acids and pathogenic and non-pathogenic E. coli with increased resistance to a number of antibiotics in experiments in vitro and in the process of treatment of patients with colienteritis].
D000409:Alanine / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001120:Arginine / Q000378:metabolism; D001224:Aspartic Acid / Q000378:metabolism; D002648:Child; D002701:Chloramphenicol / Q000494:pharmacology; D002751:Chlortetracycline / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004751:Enteritis / Q000188:drug therapy* / Q000382:microbiology; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development; D004927:Escherichia coli Infections / Q000188:drug therapy; D005971:Glutamates / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D010118:Oxytetracycline / Q000494:pharmacology; D011392:Proline / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D013307:Streptomycin / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D005971:Glutamates; D001224:Aspartic Acid; D012694:Serine; D002701:Chloramphenicol; D001120:Arginine; D011392:Proline; D000409:Alanine; D005998:Glycine; D002751:Chlortetracycline; D010118:Oxytetracycline; D013307:Streptomycin; D014756:Viomycin; D003091:Colistin
Ispol'zovanie aminokislot patogennymi i nepatogennmi E. coli, povysivshimi ustoĭchivost' k riadu antibiotikov v opytakh in vitro i v protsesse lecheniia bol'nykh koliénteritami.